FXR agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S373100

Reexamination Certificate

active

07846960

ABSTRACT:
Compounds of formula wherein variables are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and related diseases.

REFERENCES:
patent: 5990139 (1999-11-01), Yano et al.
patent: WO 03/015771 (2003-02-01), None
patent: WO 2004/048349 (2004-06-01), None
patent: WO 2005/065683 (2005-07-01), None
Morissette et al. Advanced Drug Delivery Reviews 2004, 56, 275-300.
Vippagunta et al., abstract, Vippagunta, Sudha R. “Crystalline Solids.” Advanced Drug Delivery Reviews 48(2001): 3-26.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

FXR agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with FXR agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and FXR agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4228445

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.